Global Anti-Infective Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 127 pages | ID: G3AC1D694344EN
QYResearch

Abstracts

This report focuses on the global Anti-Infective Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Infective Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• GlaxoSmithKline
• Merck
• Pfizer
• Novartis AG
• Gilead Sciences
• Abbott
• Wyeth
• Sanofi-Aventis
• Bristol-Myers Squibb
• Johnson
• Roche Pharma AG
• Nanosphere
• NanoViricides
• Novabay Pharmaceuticals
• Obetech
• Optimer Pharmaceuticals
• Basilea Pharmaceutica AG
• Daiichi Sankyo
• MerLion Pharma
• Theravance

Market segment by Type, the product can be split into

• OTC
• Rx Drugs

Market segment by Application, split into

• Hospital
• Drugs Store
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anti-Infective Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Anti-Infective Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-Infective Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Infective Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anti-Infective Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 OTC
  1.4.3 Rx Drugs
1.5 Market by Application
  1.5.1 Global Anti-Infective Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Store
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anti-Infective Treatment Market Perspective (2015-2026)
2.2 Anti-Infective Treatment Growth Trends by Regions
  2.2.1 Anti-Infective Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anti-Infective Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Anti-Infective Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anti-Infective Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Anti-Infective Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anti-Infective Treatment Players by Market Size
  3.1.1 Global Top Anti-Infective Treatment Players by Revenue (2015-2020)
  3.1.2 Global Anti-Infective Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anti-Infective Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Infective Treatment Market Concentration Ratio
  3.2.1 Global Anti-Infective Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anti-Infective Treatment Revenue in 2019
3.3 Anti-Infective Treatment Key Players Head office and Area Served
3.4 Key Players Anti-Infective Treatment Product Solution and Service
3.5 Date of Enter into Anti-Infective Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anti-Infective Treatment Historic Market Size by Type (2015-2020)
4.2 Global Anti-Infective Treatment Forecasted Market Size by Type (2021-2026)

5 ANTI-INFECTIVE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anti-Infective Treatment Market Size by Application (2015-2020)
5.2 Global Anti-Infective Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anti-Infective Treatment Market Size (2015-2020)
6.2 Anti-Infective Treatment Key Players in North America (2019-2020)
6.3 North America Anti-Infective Treatment Market Size by Type (2015-2020)
6.4 North America Anti-Infective Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anti-Infective Treatment Market Size (2015-2020)
7.2 Anti-Infective Treatment Key Players in Europe (2019-2020)
7.3 Europe Anti-Infective Treatment Market Size by Type (2015-2020)
7.4 Europe Anti-Infective Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Anti-Infective Treatment Market Size (2015-2020)
8.2 Anti-Infective Treatment Key Players in China (2019-2020)
8.3 China Anti-Infective Treatment Market Size by Type (2015-2020)
8.4 China Anti-Infective Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anti-Infective Treatment Market Size (2015-2020)
9.2 Anti-Infective Treatment Key Players in Japan (2019-2020)
9.3 Japan Anti-Infective Treatment Market Size by Type (2015-2020)
9.4 Japan Anti-Infective Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anti-Infective Treatment Market Size (2015-2020)
10.2 Anti-Infective Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Infective Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Infective Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Anti-Infective Treatment Market Size (2015-2020)
11.2 Anti-Infective Treatment Key Players in India (2019-2020)
11.3 India Anti-Infective Treatment Market Size by Type (2015-2020)
11.4 India Anti-Infective Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anti-Infective Treatment Market Size (2015-2020)
12.2 Anti-Infective Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Infective Treatment Market Size by Type (2015-2020)
12.4 Central & South America Anti-Infective Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Details
  13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline Anti-Infective Treatment Introduction
  13.1.4 GlaxoSmithKline Revenue in Anti-Infective Treatment Business (2015-2020))
  13.1.5 GlaxoSmithKline Recent Development
13.2 Merck
  13.2.1 Merck Company Details
  13.2.2 Merck Business Overview and Its Total Revenue
  13.2.3 Merck Anti-Infective Treatment Introduction
  13.2.4 Merck Revenue in Anti-Infective Treatment Business (2015-2020)
  13.2.5 Merck Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Anti-Infective Treatment Introduction
  13.3.4 Pfizer Revenue in Anti-Infective Treatment Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Anti-Infective Treatment Introduction
  13.4.4 Novartis AG Revenue in Anti-Infective Treatment Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 Gilead Sciences
  13.5.1 Gilead Sciences Company Details
  13.5.2 Gilead Sciences Business Overview and Its Total Revenue
  13.5.3 Gilead Sciences Anti-Infective Treatment Introduction
  13.5.4 Gilead Sciences Revenue in Anti-Infective Treatment Business (2015-2020)
  13.5.5 Gilead Sciences Recent Development
13.6 Abbott
  13.6.1 Abbott Company Details
  13.6.2 Abbott Business Overview and Its Total Revenue
  13.6.3 Abbott Anti-Infective Treatment Introduction
  13.6.4 Abbott Revenue in Anti-Infective Treatment Business (2015-2020)
  13.6.5 Abbott Recent Development
13.7 Wyeth
  13.7.1 Wyeth Company Details
  13.7.2 Wyeth Business Overview and Its Total Revenue
  13.7.3 Wyeth Anti-Infective Treatment Introduction
  13.7.4 Wyeth Revenue in Anti-Infective Treatment Business (2015-2020)
  13.7.5 Wyeth Recent Development
13.8 Sanofi-Aventis
  13.8.1 Sanofi-Aventis Company Details
  13.8.2 Sanofi-Aventis Business Overview and Its Total Revenue
  13.8.3 Sanofi-Aventis Anti-Infective Treatment Introduction
  13.8.4 Sanofi-Aventis Revenue in Anti-Infective Treatment Business (2015-2020)
  13.8.5 Sanofi-Aventis Recent Development
13.9 Bristol-Myers Squibb
  13.9.1 Bristol-Myers Squibb Company Details
  13.9.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.9.3 Bristol-Myers Squibb Anti-Infective Treatment Introduction
  13.9.4 Bristol-Myers Squibb Revenue in Anti-Infective Treatment Business (2015-2020)
  13.9.5 Bristol-Myers Squibb Recent Development
13.10 Johnson
  13.10.1 Johnson Company Details
  13.10.2 Johnson Business Overview and Its Total Revenue
  13.10.3 Johnson Anti-Infective Treatment Introduction
  13.10.4 Johnson Revenue in Anti-Infective Treatment Business (2015-2020)
  13.10.5 Johnson Recent Development
13.11 Roche Pharma AG
  10.11.1 Roche Pharma AG Company Details
  10.11.2 Roche Pharma AG Business Overview and Its Total Revenue
  10.11.3 Roche Pharma AG Anti-Infective Treatment Introduction
  10.11.4 Roche Pharma AG Revenue in Anti-Infective Treatment Business (2015-2020)
  10.11.5 Roche Pharma AG Recent Development
13.12 Nanosphere
  10.12.1 Nanosphere Company Details
  10.12.2 Nanosphere Business Overview and Its Total Revenue
  10.12.3 Nanosphere Anti-Infective Treatment Introduction
  10.12.4 Nanosphere Revenue in Anti-Infective Treatment Business (2015-2020)
  10.12.5 Nanosphere Recent Development
13.13 NanoViricides
  10.13.1 NanoViricides Company Details
  10.13.2 NanoViricides Business Overview and Its Total Revenue
  10.13.3 NanoViricides Anti-Infective Treatment Introduction
  10.13.4 NanoViricides Revenue in Anti-Infective Treatment Business (2015-2020)
  10.13.5 NanoViricides Recent Development
13.14 Novabay Pharmaceuticals
  10.14.1 Novabay Pharmaceuticals Company Details
  10.14.2 Novabay Pharmaceuticals Business Overview and Its Total Revenue
  10.14.3 Novabay Pharmaceuticals Anti-Infective Treatment Introduction
  10.14.4 Novabay Pharmaceuticals Revenue in Anti-Infective Treatment Business (2015-2020)
  10.14.5 Novabay Pharmaceuticals Recent Development
13.15 Obetech
  10.15.1 Obetech Company Details
  10.15.2 Obetech Business Overview and Its Total Revenue
  10.15.3 Obetech Anti-Infective Treatment Introduction
  10.15.4 Obetech Revenue in Anti-Infective Treatment Business (2015-2020)
  10.15.5 Obetech Recent Development
13.16 Optimer Pharmaceuticals
  10.16.1 Optimer Pharmaceuticals Company Details
  10.16.2 Optimer Pharmaceuticals Business Overview and Its Total Revenue
  10.16.3 Optimer Pharmaceuticals Anti-Infective Treatment Introduction
  10.16.4 Optimer Pharmaceuticals Revenue in Anti-Infective Treatment Business (2015-2020)
  10.16.5 Optimer Pharmaceuticals Recent Development
13.17 Basilea Pharmaceutica AG
  10.17.1 Basilea Pharmaceutica AG Company Details
  10.17.2 Basilea Pharmaceutica AG Business Overview and Its Total Revenue
  10.17.3 Basilea Pharmaceutica AG Anti-Infective Treatment Introduction
  10.17.4 Basilea Pharmaceutica AG Revenue in Anti-Infective Treatment Business (2015-2020)
  10.17.5 Basilea Pharmaceutica AG Recent Development
13.18 Daiichi Sankyo
  10.18.1 Daiichi Sankyo Company Details
  10.18.2 Daiichi Sankyo Business Overview and Its Total Revenue
  10.18.3 Daiichi Sankyo Anti-Infective Treatment Introduction
  10.18.4 Daiichi Sankyo Revenue in Anti-Infective Treatment Business (2015-2020)
  10.18.5 Daiichi Sankyo Recent Development
13.19 MerLion Pharma
  10.19.1 MerLion Pharma Company Details
  10.19.2 MerLion Pharma Business Overview and Its Total Revenue
  10.19.3 MerLion Pharma Anti-Infective Treatment Introduction
  10.19.4 MerLion Pharma Revenue in Anti-Infective Treatment Business (2015-2020)
  10.19.5 MerLion Pharma Recent Development
13.20 Theravance
  10.20.1 Theravance Company Details
  10.20.2 Theravance Business Overview and Its Total Revenue
  10.20.3 Theravance Anti-Infective Treatment Introduction
  10.20.4 Theravance Revenue in Anti-Infective Treatment Business (2015-2020)
  10.20.5 Theravance Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anti-Infective Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Infective Treatment Revenue
Table 3. Ranking of Global Top Anti-Infective Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Infective Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of OTC
Table 6. Key Players of Rx Drugs
Table 7. Global Anti-Infective Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Anti-Infective Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Anti-Infective Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Anti-Infective Treatment Market Share by Regions (2015-2020)
Table 11. Global Anti-Infective Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Anti-Infective Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Anti-Infective Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Anti-Infective Treatment Players
Table 18. Global Anti-Infective Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Anti-Infective Treatment Market Share by Players (2015-2020)
Table 20. Global Top Anti-Infective Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Treatment as of 2019)
Table 21. Global Anti-Infective Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anti-Infective Treatment Product Solution and Service
Table 24. Date of Enter into Anti-Infective Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Anti-Infective Treatment Market Size Share by Type (2015-2020)
Table 28. Global Anti-Infective Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Anti-Infective Treatment Market Size Share by Application (2015-2020)
Table 30. Global Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Anti-Infective Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 34. North America Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Anti-Infective Treatment Market Share by Type (2015-2020)
Table 36. North America Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Anti-Infective Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 40. Europe Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Anti-Infective Treatment Market Share by Type (2015-2020)
Table 42. Europe Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Anti-Infective Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 46. China Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Anti-Infective Treatment Market Share by Type (2015-2020)
Table 48. China Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Anti-Infective Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 52. Japan Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Anti-Infective Treatment Market Share by Type (2015-2020)
Table 54. Japan Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Anti-Infective Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 58. Southeast Asia Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Anti-Infective Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Anti-Infective Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 64. India Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Anti-Infective Treatment Market Share by Type (2015-2020)
Table 66. India Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Anti-Infective Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Anti-Infective Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Anti-Infective Treatment Market Share (2019-2020)
Table 70. Central & South America Anti-Infective Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Anti-Infective Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Anti-Infective Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Anti-Infective Treatment Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Product
Table 82. Merck Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 83. Merck Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Novartis AG Company Details
Table 90. Novartis AG Business Overview
Table 91. Novartis AG Product
Table 92. Novartis AG Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 93. Novartis AG Recent Development
Table 94. Gilead Sciences Company Details
Table 95. Gilead Sciences Business Overview
Table 96. Gilead Sciences Product
Table 97. Gilead Sciences Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 98. Gilead Sciences Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Wyeth Company Details
Table 105. Wyeth Business Overview
Table 106. Wyeth Product
Table 107. Wyeth Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 108. Wyeth Recent Development
Table 109. Sanofi-Aventis Business Overview
Table 110. Sanofi-Aventis Product
Table 111. Sanofi-Aventis Company Details
Table 112. Sanofi-Aventis Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 113. Sanofi-Aventis Recent Development
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Business Overview
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 118. Bristol-Myers Squibb Recent Development
Table 119. Johnson Company Details
Table 120. Johnson Business Overview
Table 121. Johnson Product
Table 122. Johnson Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 123. Johnson Recent Development
Table 124. Roche Pharma AG Company Details
Table 125. Roche Pharma AG Business Overview
Table 126. Roche Pharma AG Product
Table 127. Roche Pharma AG Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 128. Roche Pharma AG Recent Development
Table 129. Nanosphere Company Details
Table 130. Nanosphere Business Overview
Table 131. Nanosphere Product
Table 132. Nanosphere Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 133. Nanosphere Recent Development
Table 134. NanoViricides Company Details
Table 135. NanoViricides Business Overview
Table 136. NanoViricides Product
Table 137. NanoViricides Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 138. NanoViricides Recent Development
Table 139. Novabay Pharmaceuticals Company Details
Table 140. Novabay Pharmaceuticals Business Overview
Table 141. Novabay Pharmaceuticals Product
Table 142. Novabay Pharmaceuticals Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 143. Novabay Pharmaceuticals Recent Development
Table 144. Obetech Company Details
Table 145. Obetech Business Overview
Table 146. Obetech Product
Table 147. Obetech Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 148. Obetech Recent Development
Table 149. Optimer Pharmaceuticals Company Details
Table 150. Optimer Pharmaceuticals Business Overview
Table 151. Optimer Pharmaceuticals Product
Table 152. Optimer Pharmaceuticals Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 153. Optimer Pharmaceuticals Recent Development
Table 154. Basilea Pharmaceutica AG Company Details
Table 155. Basilea Pharmaceutica AG Business Overview
Table 156. Basilea Pharmaceutica AG Product
Table 157. Basilea Pharmaceutica AG Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 158. Basilea Pharmaceutica AG Recent Development
Table 159. Daiichi Sankyo Company Details
Table 160. Daiichi Sankyo Business Overview
Table 161. Daiichi Sankyo Product
Table 162. Daiichi Sankyo Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 163. Daiichi Sankyo Recent Development
Table 164. MerLion Pharma Company Details
Table 165. MerLion Pharma Business Overview
Table 166. MerLion Pharma Product
Table 167. MerLion Pharma Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 168. MerLion Pharma Recent Development
Table 169. Theravance Company Details
Table 170. Theravance Business Overview
Table 171. Theravance Product
Table 172. Theravance Revenue in Anti-Infective Treatment Business (2015-2020) (Million US$)
Table 173. Theravance Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anti-Infective Treatment Market Share by Type: 2020 VS 2026
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Anti-Infective Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Other Case Studies
Figure 8. Anti-Infective Treatment Report Years Considered
Figure 9. Global Anti-Infective Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Anti-Infective Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Anti-Infective Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Anti-Infective Treatment Market Share by Players in 2019
Figure 14. Global Top Anti-Infective Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Anti-Infective Treatment Revenue in 2019
Figure 16. North America Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Anti-Infective Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GlaxoSmithKline Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 25. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Merck Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 29. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis AG Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 31. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Gilead Sciences Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 33. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Abbott Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 35. Wyeth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Wyeth Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 37. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi-Aventis Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 39. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Bristol-Myers Squibb Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 41. Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Johnson Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 43. Roche Pharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Roche Pharma AG Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 45. Nanosphere Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Nanosphere Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 47. NanoViricides Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. NanoViricides Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 49. Novabay Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novabay Pharmaceuticals Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 51. Obetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Obetech Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 53. Optimer Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Optimer Pharmaceuticals Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 55. Basilea Pharmaceutica AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Basilea Pharmaceutica AG Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 57. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Daiichi Sankyo Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 59. MerLion Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. MerLion Pharma Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 61. Theravance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Theravance Revenue Growth Rate in Anti-Infective Treatment Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed